Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Arihara

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|August 22, 2025
Clinical potential of antibody-drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumorsIppei Miyamoto, Takahiro Kogawa, Kana Kurokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 30, 2013
[Bendamustine-rituximab therapy is effective for transformed follicular lymphoma with significant expression of p53]Hiroyuki Kuroda, Wataru Jomen, Shogo Miura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[Combined modality therapy for a patient with primary adrenal lymphoma]Teppei Matsuno, Hiroyuki Kuroda, Wataru Jomen, et al.
Scientific Reports|April 10, 2019
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cellsNaotaka Hayasaka, Kohichi Takada, Hajime Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 TrialCaron A Jacobson, Jason R Westin, David B Miklos, et al.
Journal of the National Cancer Institute|September 16, 2016
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal CancerTakahiro Osuga, Rishu Takimoto, Michihiro Ono, et al.
Journal of the National Cancer Institute|April 15, 2016
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal CancerTakahiro Osuga, Rishu Takimoto, Michihiro Ono, et al.
Japanese Journal of Clinical Oncology|October 4, 2023
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective studyTomohiro Kubo, Joji Muramatsu, Yohei Arihara, et al.
BMC Gastroenterology|July 18, 2023
Clinical factors associated with acute abdominal symptoms induced by gastric anisakiasis: a multicenter retrospective cohort studyYutaka Okagawa, Tetsuya Sumiyoshi, Takayuki Imagawa, et al.
Oncotarget|May 28, 2016
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicinMichihiro Ono, Rishu Takimoto, Takahiro Osuga, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|August 22, 2025
Clinical potential of antibody-drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumorsIppei Miyamoto, Takahiro Kogawa, Kana Kurokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 30, 2013
[Bendamustine-rituximab therapy is effective for transformed follicular lymphoma with significant expression of p53]Hiroyuki Kuroda, Wataru Jomen, Shogo Miura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[Combined modality therapy for a patient with primary adrenal lymphoma]Teppei Matsuno, Hiroyuki Kuroda, Wataru Jomen, et al.
Scientific Reports|April 10, 2019
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cellsNaotaka Hayasaka, Kohichi Takada, Hajime Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 TrialCaron A Jacobson, Jason R Westin, David B Miklos, et al.
Journal of the National Cancer Institute|September 16, 2016
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal CancerTakahiro Osuga, Rishu Takimoto, Michihiro Ono, et al.
Journal of the National Cancer Institute|April 15, 2016
Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal CancerTakahiro Osuga, Rishu Takimoto, Michihiro Ono, et al.
Japanese Journal of Clinical Oncology|October 4, 2023
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective studyTomohiro Kubo, Joji Muramatsu, Yohei Arihara, et al.
BMC Gastroenterology|July 18, 2023
Clinical factors associated with acute abdominal symptoms induced by gastric anisakiasis: a multicenter retrospective cohort studyYutaka Okagawa, Tetsuya Sumiyoshi, Takayuki Imagawa, et al.
Oncotarget|May 28, 2016
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicinMichihiro Ono, Rishu Takimoto, Takahiro Osuga, et al.
Pageof 5